A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Clinical trial NCT04777201 · COMPLETED
Trial details
- NCT number
- NCT04777201
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2024-09-03
- Enrollment
- 1036
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.